Compression Works Secures $3.5M Seed Round Funding to Advance Hemorrhage-Control Innovations: Hemorrhage Stops Here™

Compression Works is thrilled to announce that we have successfully raised $3,500,000 in funding to further our mission of saving lives with innovative hemorrhage-control solutions. With our slogan, "Hemorrhage Stops Here™," we are committed to combating hemorrhagic shock on both battlefields and within our communities. Our flagship product, the Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S), is revolutionizing emergency medical response by offering the only solution capable of providing stable and complete occlusion of blood flow to the lower extremities, pelvis, and upper extremities. This groundbreaking device is transforming the way traumatic injuries, including those from pelvic fractures, postpartum hemorrhaging, and junctional penetrating trauma, are managed in critical situations. Currently in use in over a dozen countries, the AAJT-S is helping to prevent deaths caused by wounds to the pelvis, inguinal region, and axilla. The funding will enable us to enhance our manufacturing capabilities, expand our global reach, and invest in research and development to ensure our products continue to meet the highest standards of efficacy and innovation. We believe that with this new capital, Compression Works will create even greater impact and ensure that no life is lost due to uncontrolled bleeding. Stay tuned for updates as we embark on this exciting new chapter, and thank you to our investors for believing in our vision and the vital role we play in emergency care. Together, we can make a difference where it matters most.